These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12519069)

  • 21. Synthesis of 7-arylmorphinans. Probing the "address" requirements for selectivity at opioid delta receptors.
    Gao P; Larson DL; Portoghese PS
    J Med Chem; 1998 Jul; 41(16):3091-8. PubMed ID: 9685249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of substitution on the pyrrole N atom in derivatives of tetrahydronaltrindole, tetrahydrooxymorphindole, and a related 4,5-epoxyphenylpyrrolomorphinan.
    Srivastava SK; Shefali S; Miller CN; Aceto MD; Traynor JR; Lewis JW; Husbands SM
    J Med Chem; 2004 Dec; 47(26):6645-8. PubMed ID: 15588100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies.
    Peng Y; Keenan SM; Zhang Q; Kholodovych V; Welsh WJ
    J Med Chem; 2005 Mar; 48(5):1620-9. PubMed ID: 15743203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of the message-address concept to the docking of naltrexone and selective naltrexone-derived opioid antagonists into opioid receptor models.
    Metzger TG; Paterlini MG; Portoghese PS; Ferguson DM
    Neurochem Res; 1996 Nov; 21(11):1287-94. PubMed ID: 8947918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 14-Desoxy analogues of naltrindole and 7-spiroindanyloxymorphone: the role of the 14-hydroxy group at delta opioid receptors.
    Kshirsagar TA; Fang X; Portoghese PS
    J Med Chem; 1998 Jul; 41(14):2657-60. PubMed ID: 9651172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Major effect of pyrrolic N-benzylation in norbinaltorphimine, the selective kappa-opioid receptor antagonist.
    Chauvignac C; Miller CN; Srivastava SK; Lewis JW; Husbands SM; Traynor JR
    J Med Chem; 2005 Mar; 48(5):1676-9. PubMed ID: 15743210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delta opioid binding selectivity of 3-ether analogs of naltrindole.
    Coop A; Pinto J; Wang L; McCullough K; Rothman RB; Dersch C; Jacobson AE; Rice KC
    Bioorg Med Chem Lett; 1999 Dec; 9(24):3435-8. PubMed ID: 10617086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of naltrexone-derived delta-opioid antagonists. Role of conformation of the delta address moiety.
    Portoghese PS; Sultana M; Moe ST; Takemori AE
    J Med Chem; 1994 Mar; 37(5):579-85. PubMed ID: 8126697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists.
    Thomas JB; Mascarella SW; Rothman RB; Partilla JS; Xu H; McCullough KB; Dersch CM; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 1998 May; 41(11):1980-90. PubMed ID: 9599247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 7'-Substituted amino acid conjugates of naltrindole. Hydrophilic groups as determinants of selective antagonism of delta 1 opioid receptor-mediated antinociception in mice.
    Portoghese PS; Farouz-Grant F; Sultana M; Takemori AE
    J Med Chem; 1995 Feb; 38(3):402-7. PubMed ID: 7853332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
    Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice.
    Reeta Kh; Mediratta PK; Rathi N; Jain H; Chugh C; Sharma KK
    Regul Pept; 2006 Jul; 135(1-2):85-90. PubMed ID: 16712978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probes for narcotic receptor mediated phenomena. 47. Novel C4a- and N-substituted-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-6-ols.
    Iyer MR; Rothman RB; Dersch CM; Jacobson AE; Rice KC
    Bioorg Med Chem; 2013 Jun; 21(11):3298-309. PubMed ID: 23618710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational evidence for a common kappa antagonist binding pocket in the wild-type kappa and mutant mu[K303E] opioid receptors.
    Jones RM; Hjorth SA; Schwartz TW; Portoghese PS
    J Med Chem; 1998 Dec; 41(25):4911-4. PubMed ID: 9836606
    [No Abstract]   [Full Text] [Related]  

  • 35. Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid kappa and delta inhibitory tone.
    Ossipov MH; Kovelowski CJ; Wheeler-Aceto H; Cowan A; Hunter JC; Lai J; Malan TP; Porreca F
    J Pharmacol Exp Ther; 1996 May; 277(2):784-8. PubMed ID: 8627559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppression by delta-opioid antagonist naltrindole: delta- and triple mu/delta/kappa-opioid receptor knockout mice reveal a nonopioid activity.
    Gavériaux-Ruff C; Filliol D; Simonin F; Matthes HW; Kieffer BL
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1193-8. PubMed ID: 11504820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo rat brain opioid receptor binding of LY255582 assessed with a novel method using LC/MS/MS and the administration of three tracers simultaneously.
    Need AB; McKinzie JH; Mitch CH; Statnick MA; Phebus LA
    Life Sci; 2007 Oct; 81(17-18):1389-96. PubMed ID: 17935738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transformation of a kappa-opioid receptor antagonist to a kappa-agonist by transfer of a guanidinium group from the 5'- to 6'-position of naltrindole.
    Sharma SK; Jones RM; Metzger TG; Ferguson DM; Portoghese PS
    J Med Chem; 2001 Jun; 44(13):2073-9. PubMed ID: 11405645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindole.
    Coop A; Jacobson AE; Aceto MD; Harris LS; Traynor JR; Woods JH; Rice KC
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2449-51. PubMed ID: 11078198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of novel twin drug consisting of 8-oxaendoethanotetrahydromorphides with a 1,4-dioxane spacer and its pharmacological activities: mu, kappa, and putative epsilon opioid receptor antagonists.
    Fujii H; Watanabe A; Nemoto T; Narita M; Miyoshi K; Nakamura A; Suzuki T; Nagase H
    Bioorg Med Chem Lett; 2009 Jan; 19(2):438-41. PubMed ID: 19042127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.